Literature DB >> 29038266

Potency of Meropenem-Vaborbactam in Lung Surfactant.

Debora Rubio-Aparicio1, Jeff Loutit1, Michael Dudley1, Olga Lomovskaya2.   

Abstract

This study investigated whether pulmonary surfactant has an effect on the in vitro antibacterial activity of either meropenem alone or meropenem in combination with vaborbactam at a fixed concentration of 8 μg/ml against several Klebsiella pneumoniae carbapenemase (KPC)-producing strains of Gram-negative bacteria. Results showed that the potency of meropenem alone and that of meropenem-vaborbactam were not affected when tested with pulmonary surfactant.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  meropenem; pulmonary surfactant; vaborbactam

Mesh:

Substances:

Year:  2017        PMID: 29038266      PMCID: PMC5740353          DOI: 10.1128/AAC.01702-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  4 in total

1.  Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases.

Authors:  Scott J Hecker; K Raja Reddy; Maxim Totrov; Gavin C Hirst; Olga Lomovskaya; David C Griffith; Paula King; Ruslan Tsivkovski; Dongxu Sun; Mojgan Sabet; Ziad Tarazi; Matthew C Clifton; Kateri Atkins; Amy Raymond; Kristy T Potts; Jan Abendroth; Serge H Boyer; Jeffrey S Loutit; Elizabeth E Morgan; Stephanie Durso; Michael N Dudley
Journal:  J Med Chem       Date:  2015-03-17       Impact factor: 7.446

2.  Inhibition of daptomycin by pulmonary surfactant: in vitro modeling and clinical impact.

Authors:  Jared A Silverman; Lawrence I Mortin; Andrew D G Vanpraagh; Tongchuan Li; Jeff Alder
Journal:  J Infect Dis       Date:  2005-05-05       Impact factor: 5.226

3.  Effect of the β-Lactamase Inhibitor Vaborbactam Combined with Meropenem against Serine Carbapenemase-Producing Enterobacteriaceae.

Authors:  Mariana Castanheira; Paul R Rhomberg; Robert K Flamm; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

4.  Meropenem-RPX7009 Concentrations in Plasma, Epithelial Lining Fluid, and Alveolar Macrophages of Healthy Adult Subjects.

Authors:  Eric Wenzler; Mark H Gotfried; Jeffrey S Loutit; Stephanie Durso; David C Griffith; Michael N Dudley; Keith A Rodvold
Journal:  Antimicrob Agents Chemother       Date:  2015-09-08       Impact factor: 5.191

  4 in total
  1 in total

Review 1.  Penetration of Antibacterial Agents into Pulmonary Epithelial Lining Fluid: An Update.

Authors:  Emily N Drwiega; Keith A Rodvold
Journal:  Clin Pharmacokinet       Date:  2021-10-15       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.